← 규제 뉴스
해외 규제동향가이던스2026. 6. 5.· FDA · openFDA

FDA CDRH 가이던스 2025~2026 발행 목록 (29건·원문 링크)

FDA CDRH가 2025년 이후 발행한 가이던스 29건을 발행일·원문 링크와 함께 정리.

미국 FDA 의료기기·방사선보건센터(CDRH)가 2025-01-01 이후 발행한 가이던스 29건(최종·초안 포함)을 발행일 순으로 정리했다. 제목의 링크는 FDA 원문으로 연결된다. 국내 RA 실무에 영향이 큰 항목은 별도 분석글에서 다룬다.

📌 29건 중 무엇부터 볼 것인가 REGNA 편집 해석

미국 진출을 준비한다면 이 목록에서 먼저 열 것은 다음 넷이다.

  • 인적요인(Human Factors) 최종 가이던스(2026-05-29) — 제출 유형이 위험도에 따라 3단계로 갈린다. 사용적합성 시험 계획을 언제 세우느냐가 일정 전체를 좌우한다.
  • 시판전신고 면제 의향(2026-06-05) — 미분류 기기 일부를 510(k) 면제로 돌리려는 문서다. 자사 품목이 대상이면 진입 비용이 크게 준다.
  • 임상의사결정지원(CDS) 소프트웨어 최종본(2026-01-29) — 소프트웨어가 «의료기기»에서 빠지는 경계를 다시 그었다. AI 기반 판독 보조를 만든다면 이 문서부터다.
  • 정형 임플란트용 환자맞춤 가이드(2026-05-07) — 3D 프린팅·맞춤형 제작을 하는 곳에 해당한다.

나머지는 품목별 510(k) 제출자료 권고가 대부분이다. 자사 품목명이 제목에 있는지로 걸러 읽으면 된다. 국내 실무 영향이 큰 항목은 별도 분석 기사에서 다룬다.

발행일구분제목(원문 링크)
06/05/2026 Final Intent to Exempt Certain Unclassified Medical Devices from Premarket Notification Requirements: Guidance for Industry and Food and Drug Administration Staff
05/29/2026 Final Content of Human Factors Information in Medical Device Marketing Submissions: Guidance for Industry and Food and Drug Administration Staff
05/07/2026 Final Patient-Matched Guides for Orthopedic Implants: Guidance for Industry and Food and Drug Administration Staff
04/20/2026 Draft Compliance Policy Regarding Premarket and Other Requirements for Certain NIOSH Approved Air-Purifying Respirators: Draft Guidance for Industry and Food and Drug Administration Staff
03/30/2026 Final Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle: Guidance for Industry, Food and Drug Administration Staff, and Other Interested Parties
03/13/2026 Final Medical Devices with Indications Associated with Weight Loss - Premarket Considerations: Guidance for Industry and Food and Drug Administration Staff
02/03/2026 Final Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions: Guidance for Industry and Food and Drug Administration Staff
02/03/2026 Final Computer Software Assurance for Production and Quality Management System Software: Guidance for Industry and Food and Drug Administration Staff
01/29/2026 Final Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff
01/23/2026 Draft Cuffless Non-invasive Blood Pressure Measuring Devices – Clinical Performance Testing and Evaluation: Draft Guidance for Industry and Food and Drug Administration Staff
01/06/2026 Final General Wellness: Policy for Low Risk Devices: Guidance for Industry and Food and Drug Administration Staff
12/18/2025 Final Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices: Guidance for Industry and Food and Drug Administration Staff
12/03/2025 Final eCopy Program for Medical Device Submissions: Guidance for Industry and Food and Drug Administration Staff
10/28/2025 Draft Menstrual Products - Performance Testing and Labeling Recommendations: Draft Guidance for Industry and Food and Drug Administration Staff
10/27/2025 Draft Quality Management System Information for Certain Premarket Submission Reviews: Draft Guidance for Industry and Food and Drug Administration Staff
09/23/2025 Final Consideration of Enforcement Policies for In Vitro Diagnostic Tests During a Section 564 Declared Emergency: Guidance for Industry and Food and Drug Administration Staff
08/22/2025 Final Animal Studies for Dental Bone Grafting Material Devices - Premarket Notification (510(k)) Submissions: Guidance for Industry and Food and Drug Administration Staff
08/18/2025 Final Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions: Guidance for Industry and Food and Drug Administration Staff
07/31/2025 Final Medical Device User Fee Small Business Qualification and Determination: Guidance for Industry, Food and Drug Administration Staff and Foreign Governments
06/06/2025 Draft Hernia Mesh – Package Labeling Recommendations: Draft Guidance for Industry and Food and Drug Administration Staff
06/05/2025 Draft Transfer of a Premarket Notification (510(k)) Clearance – Questions and Answers: Draft Guidance for Industry and Food and Drug Administration Staff
05/29/2025 Final Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program: - Final Guidance for Industry and Food and Drug Administration Staff
05/29/2025 Draft Electronic Submission Template for Medical Device Q-Submissions: Draft Guidance for Industry and Food and Drug Administration Staff
03/31/2025 Final Evaluation of Sex-Specific Data in Medical Device Clinical Studies - Guidance for Industry and Food and Drug Administration Staff
01/13/2025 Final Premarket Approval Application and Humanitarian Device Exemption Modular Review: Guidance for Industry and FDA Staff
01/07/2025 Final Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act: Guidance for Industry and Food and Drug Administration Staff
01/07/2025 Draft Pulse Oximeters for Medical Purposes - Non-Clinical and Clinical Performance Testing, Labeling, and Premarket Submission Recommendations: Draft Guidance for Industry and Food and Drug Administration S
01/07/2025 Draft Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations: Draft Guidance for Industry and Food and Drug Administration Staff
01/06/2025 Draft Validation of Certain In Vitro Diagnostic Devices for Emerging Pathogens During a Section 564 Declared Emergency: Draft Guidance for Industry and Food and Drug Administration Staff

출처: FDA CDRH Guidance Documents 데이터셋. 수집일 2026-06-11. 날짜는 FDA 표기(월/일/연) 원본.

같은 주제의 최근 뉴스

무료로 제공하는 도구입니다. 우리가 이 일을 시작한 이유 · 식약처 고시 원문에서 데이터를 만들고 결과마다 근거를 붙입니다.

레그나가 공식 원문을 바탕으로 요약·정리한 내용입니다. 참고용이며 법적 효력이 없고, 인허가 판단에는 반드시 원문을 확인하세요.